SKB565 for Injection in Advanced Solid Tumors

NCT07545265 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SKB565

Sponsor

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.